Galderma Laboratories, L.P. have announced that the US Food and Drug Administration (FDA) approved Soolantra® (ivermectin) Cream, 1% for the once-daily topical treatment of inflammatory lesions, or bumps and pimples,

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In